Insight

Photo of Martin Kaiser from icr.ac.uk

Aug 24, 2024, 12:58

Martin Kaiser: BSH/UKMS Good Practice Paper on Diagnosis and initial treatment of high-risk myeloma

The Institute of Cancer Research, shared a post on LinkedIn:

“Happy to highlight the British Society of Haematology BSH / UK Myeloma Society UKMS Good Practice Paper on Diagnosis and initial treatment of high-risk myeloma.

It is written with access challenges for patients to diagnostics and treatments in mind and can hopefully support access discussions in this context.

Also, it opens a future perspective on a route to safer treatment de-escalation for non-high-risk myeloma patients through comprehensive baseline diagnostics.”

Diagnosis and initial treatment of transplant-eligible high-risk myeloma patients: A British Society for Haematology/UK Myeloma Society Good Practice Paper

Authors: Martin Kaiser, Guy Pratt, Ceri Bygrave, Kristian Bowles, Simon Stern, Matthew Jenner, and the BSH Committee.

Martin Kaiser: BSH/UKMS Good Practice Paper on Diagnosis and initial treatment of high-risk myeloma

Source:

cancer Ceri Bygrave Guy Pratt high-risk myeloma Kristian Bowles Martin Kaiser Matthew Jenner OncoDaily Oncology ritish Society of Haematology Simon Stern the BSH Committee UK Myeloma Society

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

Highlights from ELCC 2025

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

Meet the New AACR Board of Directores for 2025-2028 Term

Do Artificial Sweeteners Cause Cancer? Myths and Facts